Icon Group today announced a sizeable investment to acquire Hong Kong’s oncology-focused group, SunTech Medical Group (“SunTech Medical”) to meet the growing cancer burden and support patients in getting timely access to oncology specialists.
澳洲領先癌症綜合服務供應商Icon集團今天宣布將在高盛集團的支持下，以巨額收購香港癌症醫療專家SunTech Medical Group (“SunTech Medical”)，旨在緩解市場對癌症治療的需求，並確保癌症病患者能夠早日獲得專家的診治。
Icon Group offers comprehensive cancer care combining day oncology with radiation oncology, chemotherapy compounding and pharmacy, supported by an international network of expert clinicians, to provide end-to-end cancer services to patients as close to home as possible. Icon’s acquisition of SunTech Medical Group represents another step forward in its strategic expansion into the Asia Pacific region to close the gap in access to cancer care treatments.
Icon集團除了匯聚了全球最優秀的臨床腫瘤科醫生，更擁有一套全面的癌症護理設施，包括日間化療、放射治療、化學醫療及藥劑服務等，為病人提供一站式的癌症護理服務。是次收購不但深化集團在亞洲的拓展策略，更展現了其希望把優質癌症護理帶給更多癌症病人的宏願。
Mark Middleton, CEO of Icon Group said: “Hong Kong’s cancer spend is expected to nearly double from HKD $13 billion to over HKD $24 billion by 2026 due to an ageing population and increase in medical tourism from mainland China. We see an opportunity to complement existing cancer care providers by increasing capacity in the market to meet this growing demand. As such, we have sought out a partner who is equally committed to providing the very best services in this area and we have found this in SunTech Medical Group.”
Icon 集團行政總裁 Mark Middleton 表示：「隨著人口老化，加上內地癌症病人來港求診的趨勢漸趨明顯，香港癌症治療開支預計將由130億倍增到2026年的240億。為迎合癌症護理服務日益增長的需求，我們希望與SunTech Medical合作，補充現有的醫療服務，為本港癌症病人提供更多、更優質的護理。」
“The founding clinicians of SunTech Medical represent the pinnacle of exceptional expertise and quality of care. Coupling SunTech Medical’s strong clinical leadership and local reputation for excellence and Icon’s Group’s investment in world class technology, education and training, we have formed a strong, synergistic partnership that ensures we can deliver the best cancer care possible, to as many people as possible in Hong Kong and the surrounding region.”
「SunTech Medical的創辦人均擁有崇高的專業知識和經驗。是次收購將結合SunTech在本地的專業團隊及Icon集團擁有的先進醫療技術及培訓，把最優質的癌症護理帶給更多在港及附近地區的病患者。」
SunTech Medical was founded by some of the top clinical oncologists and colorectal surgeons in Hong Kong and comprises of a network of renowned specialists. With a philosophy of providing high quality, personalised care, SunTech and Icon share the same values of patient-centred care and an equal commitment to facing the global cancer burden by using the latest technologies.
SunTech Medical 由本港資深臨床腫瘤科及結直腸外科醫生成立，擁有一個強大的知名腫瘤科專家網絡。兩間集團均秉持著以病人為本的理念，致力為病人提供卓越以及個人化的癌症護理服務，務求以最先進的科技減輕癌症對全球造成的負擔。
“We are delighted to have partnered with Icon Group and introduce them into the Hong Kong market. This partnership will strengthen our capabilities to deliver exceptional care and sustain our projected growth plan that enables ongoing investment into the best cancer technology and specialists. We look forward to joining Icon on their mission to support as many patients as we can to navigate their individual cancer journeys,” said Dr. Peter Man-Lung TEO, Chairman of SunTech Medical.
SunTech Medical 集團主席張文龍臨床腫瘤科醫生表示：「我們很高興能與Icon集團合作並將他們的豐富經驗引入香港。這次的合作除了提升了我們對癌症護理的能力外，亦讓我們可以繼續投放資源於癌症醫療技術及專家上。我們期待與Icon一起幫助更多的癌症病人，陪伴他們對抗癌症。」
“Icon Group has a proven track record of delivering quality integrated cancer care services across Australia, New Zealand and Singapore, alongside partnerships in mainland China, and we’re excited to expand our expertise into a new market. This is another step forward in establishing our capabilities in the APAC region and will enable us to continue to bring our cancer care expertise to areas of unmet need, especially in Asia,” concluded Mr Middleton.
「Icon集團一直致力提供優質的綜合癌症護理服務，合作項目橫蓋亞太地區，包括澳洲、紐西蘭、新加坡以及中國內地。我們很高興可以將專業知識及經驗引進新的市場。這次收購進一步鞏固了我們在亞洲的實力，並讓更多地方得益。」Mark Middleton總括。
The acquisition of SunTech Medical complements Icon Group’s existing services in Singapore and mainland China. In Singapore, the Group currently has seven state-of-the-art Icon cancer centres and recently signed a partnership with Mount Alvernia Hospital that will see Icon invest in a new comprehensive and integrated cancer centre on site. In mainland China, Icon signed a partnership with the renowned Sanbo Hospital Group and United Family Healthcare Group that will see Icon introduce and deliver radiation oncology services in the 2019-2020 financial year.
Icon 集團收購SunTech Medical 的項目，使新加坡及中國內地現有的服務更完善。集團在新加坡共設有七個先進的Icon癌症中心，最近亦與安微尼亞山醫院(Mount Alvernia Hospital)簽訂合作協議，將會於該醫院投資設立一個全新完善及綜合的癌症中心。至於中國內地，Icon亦與知名的Sanbo Hospital Group 及和睦家醫院(United Family Healthcare Group)簽訂協議，將會於2019-2020財政年度實施引入及提供放射治療服務。
The acquisition is expected to complete in October 2019.
是次收購預期將於2019年十月完成。
